Cardiovascular Systems Inc. (CSII)

47.19
1.00 2.10
NASDAQ : Health Technology
Prev Close 48.21
Open 48.15
Day Low/High 47.23 / 48.75
52 Wk Low/High 24.84 / 52.54
Volume 75.30K
Avg Volume 279.10K
Exchange NASDAQ
Shares Outstanding 35.21M
Market Cap 1.73B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Cardiovascular Systems Completes PMA Submission Of Orbital Atherectomy System For Coronary Artery Disease Treatment

Cardiovascular Systems Completes PMA Submission Of Orbital Atherectomy System For Coronary Artery Disease Treatment

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced today that it has submitted its Premarket Approval (PMA) application to the U.

Cardiovascular Systems’ Orbital Atherectomy Technology Highlighted At ACC Innovations Forum

Cardiovascular Systems’ Orbital Atherectomy Technology Highlighted At ACC Innovations Forum

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), was featured as part of the “Innovation and Technology Adoption” presentation during the Innovations Educational Forum at the 2013 American College of Cardiology...

Cardiovascular Systems Presents Results From Pivotal Coronary Trial At ACC

Cardiovascular Systems Presents Results From Pivotal Coronary Trial At ACC

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), presented pivotal 30-day data from its ORBIT II study of severely calcified coronary lesions at the 2013 American College of Cardiology (ACC) conference in San...

Cardiovascular Systems To Present Pivotal Orbit II Coronary Data At The 2013 American College Of Cardiology Conference

Cardiovascular Systems To Present Pivotal Orbit II Coronary Data At The 2013 American College Of Cardiology Conference

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), will present data from its ORBIT II study of coronary artery disease at the 2013 American College of Cardiology (ACC) conference in San Francisco, Mar.

CSI Presents Three-Year Orbit I Coronary Data At CRT 2013

CSI Presents Three-Year Orbit I Coronary Data At CRT 2013

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today presented three-year data from its ORBIT I feasibility study of calcified coronary lesions during a poster session at the 2013 Cardiovascular Research ...

Cardiovascular Systems Sponsoring Orbital Atherectomy Sessions At ICON 2013

Cardiovascular Systems Sponsoring Orbital Atherectomy Sessions At ICON 2013

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), announced today it is sponsoring a challenging case presentation featuring its peripheral orbital atherectomy system, and co-hosting an office-based lab presentation...

Cardiovascular Systems To Present Three-Year Orbit I Coronary Data At 2013 Cardiovascular Research Technologies Conference

Cardiovascular Systems To Present Three-Year Orbit I Coronary Data At 2013 Cardiovascular Research Technologies Conference

Cardiovascular Systems, Inc. (CSI) (Nasdaq:CSII), will present three-year data from its ORBIT I study of coronary artery disease (CAD) in a poster session at the 2013 Cardiovascular Research Technologies (CRT)...

Cardiovascular Systems Reports Fiscal 2013 Second-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2013 Second-Quarter Financial Results

Cardiovascular Systems, Inc. (Nasdaq: CSII): Revenues of $25.

Cardiovascular Systems To Webcast Fiscal 2013 Second-Quarter Earnings Conference Call Wednesday, Jan. 30

Cardiovascular Systems To Webcast Fiscal 2013 Second-Quarter Earnings Conference Call Wednesday, Jan. 30

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2013 second-quarter conference call on Wednesday, Jan.

CSI Presents Late-Breaking Data At ISET 2013

CSI Presents Late-Breaking Data At ISET 2013

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced CONFIRM study series data presented at the 2013 International Symposium on Endovascular Therapy (ISET).

Cardiovascular Systems Releasing Late-Breaking Confirm Series Data At ISET Conference

Cardiovascular Systems Releasing Late-Breaking Confirm Series Data At ISET Conference

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), will present late-breaking data from its CONFIRM study series, an oral abstract from its CALCIUM study, and conduct other educational and poster sessions at the 25 th...

Cardiovascular Systems Completes Patient Enrollment In Orbit II Coronary Trial

Cardiovascular Systems Completes Patient Enrollment In Orbit II Coronary Trial

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), today announced it has completed enrollment in its ORBIT II clinical trial, enrolling 443 patients.

Cardiovascular Systems Featuring Training Lab At VEITH 2012

Cardiovascular Systems Featuring Training Lab At VEITH 2012

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), is offering 2012 VEITHsymposium™ attendees an opportunity to learn about the effectiveness of orbital atherectomy in treating peripheral arterial disease (PAD).

Cardiovascular Systems Reports Fiscal 2013 First-Quarter Financial Results

Cardiovascular Systems Reports Fiscal 2013 First-Quarter Financial Results

Cardiovascular Systems, Inc. (NASDAQ: CSII): Revenues rose to $23.

Cardiovascular Systems To Webcast Fiscal 2013 First-Quarter Earnings Conference Call Tuesday, Oct. 30

Cardiovascular Systems To Webcast Fiscal 2013 First-Quarter Earnings Conference Call Tuesday, Oct. 30

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2013 first-quarter conference call on Tuesday, Oct.

Leading Physicians To Unveil New Findings Regarding Arterial Calcification At TCT Conference

Leading Physicians To Unveil New Findings Regarding Arterial Calcification At TCT Conference

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced today that new findings regarding arterial calcification will be unveiled at the 2012 Transcatheter Cardiovascular Therapeutics (TCT) conference in Miami,...

CSI Presents Late-Breaking CONFIRM Series Data At VIVA 2012

CSI Presents Late-Breaking CONFIRM Series Data At VIVA 2012

Data presented yesterday from Cardiovascular Systems’ (CSI) (NASDAQ: CSII) CONFIRM study series demonstrate that CSI’s minimally invasive orbital atherectomy system is an effective treatment for peripheral ...

Cardiovascular Systems To Release Late-Breaking Peripheral Data At VIVA Conference And Introduce New CSIQ Medical Education Programs

Cardiovascular Systems To Release Late-Breaking Peripheral Data At VIVA Conference And Introduce New CSIQ Medical Education Programs

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), will present data from its CONFIRM study series at the 10 th annual VIVA conference in Las Vegas, Oct.

Clinically Significant 12-Month Results From Cardiovascular Systems' Calcium 360° Study Published In Journal Of Endovascular Therapy

Clinically Significant 12-Month Results From Cardiovascular Systems' Calcium 360° Study Published In Journal Of Endovascular Therapy

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today announced publication of 12-month...

Cardiovascular Systems To Present At Stifel Nicolaus Healthcare Conference, September 5, 2012

Cardiovascular Systems To Present At Stifel Nicolaus Healthcare Conference, September 5, 2012

Cardiovascular Systems, Inc. (Nasdaq: CSII), a medical device company developing and commercializing innovative, interventional treatment systems for vascular disease, will present at the Stifel Nicolaus 2012 ...

Cardiovascular Systems Announces Physician Training And Educational Opportunities At AMP Chicago 2012 Symposium

Cardiovascular Systems Announces Physician Training And Educational Opportunities At AMP Chicago 2012 Symposium

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today announced a slate of training and...

Cardiovascular Systems Reports Fiscal 2012 Fourth-Quarter And Full-Year Financial Results

Cardiovascular Systems Reports Fiscal 2012 Fourth-Quarter And Full-Year Financial Results

Cardiovascular Systems, Inc. (Nasdaq: CSII): Revenue gains continue Revenues of $22.

Cardiovascular Systems To Webcast Fiscal 2012 Fourth-Quarter Earnings Conference Call Wednesday, Aug. 8

Cardiovascular Systems To Webcast Fiscal 2012 Fourth-Quarter Earnings Conference Call Wednesday, Aug. 8

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2012 fourth-quarter conference call on Wednesday, Aug.

Cardiovascular Systems Announces First Patients Treated With New Electric Orbital Atherectomy System In ORBIT II Coronary Trial

Cardiovascular Systems Announces First Patients Treated With New Electric Orbital Atherectomy System In ORBIT II Coronary Trial

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today announced that two patients at two...

Cardiovascular Systems Announces Five Abstract Presentations At Upcoming C3 Conference

Cardiovascular Systems Announces Five Abstract Presentations At Upcoming C3 Conference

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today announced that five abstracts focusing...

Cardiovascular Systems Reports Data From Compliance 360° Study Comparing Orbital Atherectomy Vs. Percutaneous Transluminal Angioplasty

Cardiovascular Systems Reports Data From Compliance 360° Study Comparing Orbital Atherectomy Vs. Percutaneous Transluminal Angioplasty

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), shared 12-month data from the COMPLIANCE 360° study of severely calcified above-the-knee lesions at the New Cardiovascular Horizons Annual Conference on Saturday,...

Cardiovascular Systems Announces Pricing Of Public Offering Of Common Stock

Cardiovascular Systems Announces Pricing Of Public Offering Of Common Stock

Cardiovascular Systems, Inc. (“CSI”) (Nasdaq: CSII), a medical device company focused on developing and commercializing innovative interventional treatment systems for vascular disease, today announced the...

Cardiovascular Systems To Webcast Fiscal 2012 Third-Quarter Earnings Conference Call Wednesday, May 2

Cardiovascular Systems To Webcast Fiscal 2012 Third-Quarter Earnings Conference Call Wednesday, May 2

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) will host a live webcast of its fiscal 2012 third-quarter conference call on Wednesday, May 2, 2012, at 3:45 p.

Cardiovascular Systems’ Data For Treatment Of Peripheral Arterial Disease In Office-Based Lab Settings Presented At Society For Interventional Radiology Meeting

Cardiovascular Systems’ Data For Treatment Of Peripheral Arterial Disease In Office-Based Lab Settings Presented At Society For Interventional Radiology Meeting

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), today announced results from a study of patients treated for peripheral arterial disease (PAD) with CSI’s Diamondback™ Orbital Atherectomy System in a ...

Cardiovascular Systems’ 12-Month Data From COMPLIANCE 360° Study Of Above-the-Knee Peripheral Arterial Disease Presented At ACC

Cardiovascular Systems’ 12-Month Data From COMPLIANCE 360° Study Of Above-the-Knee Peripheral Arterial Disease Presented At ACC

Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), today presented 12-month data from the COMPLIANCE 360° study of severely calcified above-the-knee lesions at the American College of Cardiology’s (ACC) 61 st ...

TheStreet Quant Rating: C (Hold)